Seven Covid Jabs As Third Dose Can Boost Immunity: Study
Mohammad Ali (@ChaudhryMAli88) Published December 03, 2021 | 05:21 PM
Seven jabs used as boosters against Covid-19 mostly produced a strong immune response, though results varied depending on the vaccine combination, a study said Friday
Paris, Dec 3 (UrduPoint / Pakistan Point News - 3rd Dec, 2021 ) :Seven jabs used as boosters against Covid-19 mostly produced a strong immune response, though results varied depending on the vaccine combination, a study said Friday.
Last June researchers in the UK looked at about 3,000 people to compare various combinations of jabs and their effects after a third dose.
Patients in the study, published in leading medical journal The Lancet, had been fully vaccinated either with AstraZeneca or Pfizer/BioNTech.
At least two months after the second dose of Pfizer and three months for AstraZeneca, they received a third jab either of those two shots or CureVac, Moderna, Novavax, Valneva or Janssen.
Other participants received a placebo.
In nearly all patients except for those who received a placebo, participants produced an increased antibody response -- with the exception of initial vaccination by Pfizer followed by a Valneva booster, which showed no noticeable difference.
"All of the vaccines that boosted immunity did so in older and younger people; however, there were marked differences in response between specific booster vaccines, consistent with other data from non-randomised studies," the study said.
There were several limits to the study.
The third doses were administered soon after the second dose -- sometimes less time elapsed between the second and third doses than between the first and second ones, which could have reduced immunity.
But even more importantly, the study measured subjects' immune responses but did not test their real efficacy against Covid-19 infection or severity of illness.
Follow-up on the subjects will look at their immunity levels between seven and eight months after their first doses, with results expected next year.
The study also looked at side effects, which it said varied in intensity but were deemed acceptable regardless of the combination.
Related Topics
Recent Stories
Mired in crisis, Boeing reports another loss
Session Awarding Ceremony 2024 held at Cadet College Muzaffarabad
Austrian ski great Hirscher to make comeback under Dutch flag
Pakistan, Japan agrees to convene 'Economic Policy Dialogue'
FM Dar conveys deepest sympathy on torrential rains devastation in UAE
Spain PM Sanchez says weighing resignation after wife's graft probe
Tennis: ATP/WTA Madrid Open results - 1st update
Long-lost Klimt portrait auctioned off for 30 mn euros
Osaka seals first win on clay since 2022 in Madrid
Earthquake jolts Karachi
Sindh minister orders operation after attack on police in Ghotki
TikTok to fight US ban law in courts
More Stories From Health
-
Vaccines save at least 154 million lives in 50 years: WHO
6 hours ago -
UHS to issue MBBS degrees within three months after final result
9 hours ago -
Rawalpindi woman gives birth to six babies
5 days ago -
DC calls for intensive anti-polio drive in ICT
6 days ago -
World Hemophilia Day observed to underscore importance of providing comprehensive care
7 days ago -
Six in a family with heart on the 'right side'
7 days ago
-
Diabetic disease increasing rapidly : Dr. Noor Elahi Memon
7 days ago -
World Hemophilia Day observed
7 days ago -
ATC dismisses bail petition of doctor involved in illegal kidneys transplant
15 days ago -
Dr. Shehzad warns against deviation from WHO guidelines on anti-smoking
15 days ago -
Health activists express concerns over attempts to derail tobacco control
17 days ago -
UHS declares MBBS first prof, MS urology exam results
26 days ago